
News|Articles|October 5, 2026
Logipharma USA 2026: Building Resilient Supply Chains at Scale
Author(s)Stephen Appezzato, Christopher Cole
At LogiPharma USA 2026, leaders from J&J, Sun Pharma, Accord Healthcare, and Freehand discussed visibility, redundancy tradeoffs, and AI's role in resilient pharma supply chains.
Advertisement
Advertisement
Supply chain resilience is no longer about checking boxes on a risk register. It is about keeping options open, seeing deeper into the supplier network, and deciding where redundancy is worth its price. That was the consensus of the keynote panel "Building Resilient Supply Chains at Scale: Preparing for Disruption, Uncertainty & What's Next" at
Related to this article

Octapharma USA's Kerem Tokel, a LogiPharma USA 2026 freight security panelist, discusses theft hotspots, the export of stolen pharmaceutical loads and how to tighten chain of custody.

At LogiPharma USA 2026, Mark Talens explains how end-to-end visibility lets pharma see its value chain across functions, and where supply chain monitoring is headed next.

In this week’s Pharma Pulse, the FDA launches a program that lets companies share its approval packages with foreign regulators, UPS agrees to acquire Australia and New Zealand health care courier Smartways Logistics and Cognizant introduces an AI-enabled patient hub offering.

McKesson's Gene Cavacini on how pharmaceutical distributors manage drug shortages, DSCSA requirements and cold-chain capacity to keep medicines moving.

UPS' deal for Smartways Logistics adds a dedicated health care courier network in Australia and New Zealand to its Asia Pacific buildout.

APIIC's Brian Doty on how repurposing shuttered U.S. plants with advanced manufacturing could make domestic generic drug production viable.

Fragmented data is eroding trust in pharma insights, and AI raises the stakes. A four-step approach can help organizations pay down their “data debt.”
Advertisement
Advertisement

